Robert Groves – författare

For over 100 years, the evolution of modern survey methodology?using the theory of representative sampling to make interferences from a part of the population to the whole?has been paralleled by a drive toward automation, harnessing technology and computerization to make parts of the survey process easier, faster, and better. The availability of portable computers in the late 1980s ushered in computer-assisted personal interviewing (CAPI), in which interviewers administer a survey instrument to respondents using a computerized version of the questionnaire on a portable laptop computer. Computer assisted interviewing (CAI) methods have proven to be extremely useful and beneficial in survey administration. However, the practical problems encountered in documentation and testing CAI instruments suggest that this is an opportune time to reexamine not only the process of developing CAI instruments but also the future directions of survey automation writ large.

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results. The evolution and future of lung cancer screeningsDetection and management of unexpected incidental pulmonary and non-pulmonary findingsDiscussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screeningsBenefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis ratesThis state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.